{"id":59542,"date":"2020-04-18T08:30:53","date_gmt":"2020-04-18T06:30:53","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=59542"},"modified":"2020-04-17T12:01:29","modified_gmt":"2020-04-17T10:01:29","slug":"eon-nanodrugs-investment","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/","title":{"rendered":"Successful Series B financing round for Leon-Nanodrugs"},"content":{"rendered":"<div class=\"entry-content\">\n<p><strong>Leon Nanodrugs \u2014 \u201cLeon\u201d for short \u2014<\/strong>\u00a0<strong>can with<\/strong>\u00a0<strong>Lead investor Evotec SE<\/strong>\u00a0<strong>and the BayBG Bavarian investment company<\/strong>\u00a0<strong>Successfully completed Series B financing round. At the same time, existing shareholders TVM Life Science Innovation I LP, CD-Venture, Albany Private Equity Holdings Pty Ltd., Eckenstein-Geigy Foundation, and LOF Leon Partnership increased their investment.<\/strong>\u00a0<strong>With the additional capital, the Munich-based startup, founded in 2011, plans to further develop and industrialize its production technology. It also plans to expand its patent portfolio and implement additional innovations.<\/strong> <strong>The amount of the investment was not communicated.<\/strong><\/p>\n\n\n\n<p>The <a href=\"\/en\/3556\/capital-injection-leon-nanodrugs-raises-e185-million-in-series-a-financing-round\/\">Leon<\/a> The developed and patented MicroJetReactor (MJR) platform technology enables the production of nanoparticles from a wide variety of drug classes. This high-output production technology provides sufficiently small particle sizes and precision for many pharmaceuticals, while maintaining high efficacy. The tiny particles exhibit advantageous solubility, thus addressing the problem of insufficient water solubility of numerous pharmaceuticals.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">\u201cThe current financing round enables us to further develop our technology and enter the clinical phase.\u201d<\/h2>\n\n\n\n<p>Leon is conducting development work in collaboration with the developing pharmaceutical company. The Munich-based startup is currently working on four development projects with other pharmaceutical companies. The biotechnology group Evotec SE will be the development partner for numerous projects in the early formulation phase of drug development.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;We are very pleased to have gained BayBG, another renowned venture capital investor for our groundbreaking technology, alongside our strategic investor Evotec. The current financing round enables us to further develop our technology and move it into the clinical phase,&quot;<\/p><\/blockquote>\n\n\n\n<p>so <strong>Andrea Cusack<\/strong>, Managing Director of <a href=\"https:\/\/www.leon-nanodrugs.com\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\"Leon-Nanodrugs (opens in new tab)\">Leon Nanodrugs<\/a>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Highly innovative production technology<\/h2>\n\n\n\n<p><strong>Peter Graf,<\/strong> Investment Manager of <a href=\"\/en\/10276\/baybg-venture-capital\/\">BayBG<\/a>:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;Leon-Nanodrugs has a highly innovative production technology that enables the reformulation of existing active ingredients based on nanoparticles. The resulting drugs exhibit significantly improved properties compared to the original drugs, to the benefit of patients, physicians, and health insurance companies. We are pleased and proud to be part of Leon-Nanodrugs&#039; Series B financing round as a partner in a very strong consortium.&quot;<\/p><\/blockquote>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Leon-Nanodrugs \u2014 &quot;Leon&quot; for short \u2014 has successfully completed a Series B financing round with lead investor Evotec SE and BayBG Bayerische Beteiligungsgesellschaft. At the same time, existing shareholders TVM Life Science Innovation I LP, CD-Venture, Albany Private Equity Holdings Pty Ltd., Eckenstein-Geigy Foundation, and LOF Leon Partnership have increased their investment. The Munich-based startup, founded in 2011, plans to use the additional capital to...<\/p>","protected":false},"author":24,"featured_media":59558,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1,5635],"tags":[284,52,1171],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Erfolgreiche Finanzierungrunde f\u00fcr Leon-Nanodrugs<\/title>\n<meta name=\"description\" content=\"Leon-Nanodrugs kann mit Lead-Investor Evotec SE und der BayBG Bayerische Beteiligungsgesellschaft eine Series B-Finanzierungsrunde erfolgreich abschlie\u00dfen.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Erfolgreiche Finanzierungrunde f\u00fcr Leon-Nanodrugs\" \/>\n<meta property=\"og:description\" content=\"Leon-Nanodrugs kann mit Lead-Investor Evotec SE und der BayBG Bayerische Beteiligungsgesellschaft eine Series B-Finanzierungsrunde erfolgreich abschlie\u00dfen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-18T06:30:53+00:00\" \/>\n<meta name=\"author\" content=\"Regina Bruckschl\u00f6gl\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Regina Bruckschl\u00f6gl\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/\",\"url\":\"https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/\",\"name\":\"Erfolgreiche Finanzierungrunde f\u00fcr Leon-Nanodrugs\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/04\/helloquence-OQMZwNd3ThU-unsplash.jpg\",\"datePublished\":\"2020-04-18T06:30:53+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f\"},\"description\":\"Leon-Nanodrugs kann mit Lead-Investor Evotec SE und der BayBG Bayerische Beteiligungsgesellschaft eine Series B-Finanzierungsrunde erfolgreich abschlie\u00dfen.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/04\/helloquence-OQMZwNd3ThU-unsplash.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/04\/helloquence-OQMZwNd3ThU-unsplash.jpg\",\"width\":2400,\"height\":1602,\"caption\":\"Insurtech Patente Leon-Nanodrugs\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Erfolgreiche Series B-Finanzierungsrunde f\u00fcr Leon-Nanodrugs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f\",\"name\":\"Regina Bruckschl\u00f6gl\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g\",\"caption\":\"Regina Bruckschl\u00f6gl\"},\"description\":\"Nach eigenen Startup-Erfahrungen blickt sie als Redakteurin von Munich Startup nun aus einer anderen Perspektive auf die M\u00fcnchner Startup-Szene \u2013 und entdeckt dabei jeden Tag, wie vielf\u00e4ltig das M\u00fcnchner \u00d6kosystem ist. Startup Stories, die erz\u00e4hlt werden wollen!\",\"sameAs\":[\"https:\/\/cms.munich-startup.net\"],\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/regina\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2020\/04\/helloquence-OQMZwNd3ThU-unsplash.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2400\" \/>\n\t<meta property=\"og:image:height\" content=\"1602\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Successful financing round for Leon-Nanodrugs","description":"Leon-Nanodrugs successfully completes a Series B financing round with lead investor Evotec SE and BayBG Bayerische Beteiligungsgesellschaft.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/","og_locale":"en_US","og_type":"article","og_title":"Erfolgreiche Finanzierungrunde f\u00fcr Leon-Nanodrugs","og_description":"Leon-Nanodrugs kann mit Lead-Investor Evotec SE und der BayBG Bayerische Beteiligungsgesellschaft eine Series B-Finanzierungsrunde erfolgreich abschlie\u00dfen.","og_url":"https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2020-04-18T06:30:53+00:00","author":"Regina Bruckschl\u00f6gl","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Regina Bruckschl\u00f6gl","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/","url":"https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/","name":"Successful financing round for Leon-Nanodrugs","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/04\/helloquence-OQMZwNd3ThU-unsplash.jpg","datePublished":"2020-04-18T06:30:53+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f"},"description":"Leon-Nanodrugs successfully completes a Series B financing round with lead investor Evotec SE and BayBG Bayerische Beteiligungsgesellschaft.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/04\/helloquence-OQMZwNd3ThU-unsplash.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/04\/helloquence-OQMZwNd3ThU-unsplash.jpg","width":2400,"height":1602,"caption":"Insurtech Patente Leon-Nanodrugs"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/en\/59542\/eon-nanodrugs-investment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Erfolgreiche Series B-Finanzierungsrunde f\u00fcr Leon-Nanodrugs"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f","name":"Regina Bruckschl\u00f6gl","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g","caption":"Regina Bruckschl\u00f6gl"},"description":"After her own startup experiences, she now looks at the Munich startup scene from a different perspective as an editor at Munich Startup \u2013 and discovers every day how diverse the Munich ecosystem is. Startup stories that beg to be told!","sameAs":["https:\/\/cms.munich-startup.net"],"url":"https:\/\/cms.munich-startup.net\/en\/author\/regina\/"}]},"og_image":[{"width":2400,"height":1602,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/04\/helloquence-OQMZwNd3ThU-unsplash.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1587126828:33","_edit_last":"33","_yoast_wpseo_focuskw":"Leon-Nanodrugs","_yoast_wpseo_metadesc":"Leon-Nanodrugs kann mit Lead-Investor Evotec SE und der BayBG Bayerische Beteiligungsgesellschaft eine Series B-Finanzierungsrunde erfolgreich abschlie\u00dfen.","_yoast_wpseo_linkdex":"74","_thumbnail_id":"59558","wbounce_status":"default","_yoast_wpseo_primary_category":"5633","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"60","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"","ms_post_image_credit":"","_ms_post_image_credit":"","suppress_startupbox":"","_suppress_startupbox":"","_yoast_wpseo_estimated-reading-time-minutes":"","_wp_old_date":"","_yoast_wpseo_title":"Erfolgreiche Finanzierungrunde f\u00fcr Leon-Nanodrugs","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/59542"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=59542"}],"version-history":[{"count":4,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/59542\/revisions"}],"predecessor-version":[{"id":59600,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/59542\/revisions\/59600"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/59558"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=59542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=59542"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=59542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}